Corvus Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Corvus Pharmaceuticals, Inc.

Jun-25	Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis CRVS GlobeNewswire
Jun-11	Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data Highlighting Potential of ITK inhibition to Treat Systemic Sclerosis at EULAR 2025 Congress CRVS GlobeNewswire
Jun-04	Corvus Pharmaceuticals Announces Full Data from Cohort 3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis CRVS GlobeNewswire
May-28	Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference CRVS GlobeNewswire
May-08	Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2025 Financial Results CRVS GlobeNewswire
May-08	Corvus Pharmaceuticals Announces Data from Cohorts 1-3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis CRVS GlobeNewswire